Skip to main content

Fiscal Wizard · Single-issue tearsheet

NVO / Jun 22, 2026 Run #7669

NVO

Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Composite verdict

D 39.1 / 100
Bearish setup · Mean Reversion 9 drivers · 3 gates blocking
  • Vortex Signal
  • Stochastic RSI
  • Double 7s
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 9th of 22 in Drug Manufacturers - General

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 18 signals100% Bear
Momentum Bearish 12Mean-reversion Bearish 39

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -72%
Asset value $57.87Earnings power value $300.78Price $43.19

Trading below its asset value ($57.87/share) — deep value, but check for a melting balance sheet.

Fundamentals Strong

78.2 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Cash Conversion Cycle 100
Margin of Safety 0
Free Cash Flow Yield 100
Cash Conversion 0
Greenblatt EY 100
Inventory Turnover 0

Technicals Bearish

0.1 / 100

Bearish setup leads (Vortex Signal, Stochastic RSI, Double 7s); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Vortex Signal 11
Stochastic RSI 12
Aroon Oscillator 18

Risk Gates

3 blocking 7 caution

3 guards active, 23 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for NVO.